Reuters logo
BRIEF-‍Mylan invalidates Allergan's patents on Restasis​
October 17, 2017 / 1:37 AM / a month ago

BRIEF-‍Mylan invalidates Allergan's patents on Restasis​

Oct 17 (Reuters) - Mylan Nv

* ‍Mylan invalidates Allergan’s patents on Restasis​

* U.S. district court for Eastern District of Texas issued decision finding asserted claims of patents relating to Restasis invalid ​

* ‍Court concluded “Allergan is not entitled to renewed patent rights for Restasis in form of a second wave of patent protection”​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below